What is downregulation of MHC?
MHC class I downregulation is an important mechanism of tumour escape from T cell-mediated immune responses. Approximately 40-90% of human tumours derived from various MHC class I+ tissues were reported to be MHC class I deficient.
What do MHC genes regulate?
The products of the MHC class I (MHC-I) and MHC class II (MHC-II) genes encode cell-surface glycoproteins involved in the binding and presentation of peptides to the T cell receptors (TCRs) of T lymphocytes.
How is MHC expression regulated?
Given this critical role, MHC-I and MHC-II genes are regulated in a tight fashion at the transcriptional level by a variety of transcription factors that interact with conserved cis-acting regulatory promoter elements.
What are MHC restrictions?
MHC-restricted antigen recognition, or MHC restriction, refers to the fact that a T cell can interact with a self-major histocompatibility complex molecule and a foreign peptide bound to it, but will only respond to the antigen when it is bound to a particular MHC molecule.
Which immune cell will target on the infected cell with downregulation of MHC class I molecules?
Cytotoxic CD8+ T cells provide protection by recognizing viral peptides loaded onto MHC-I molecules on the cell surface of infected cells, which triggers the delivery of cytotoxic molecules and releasing antiviral cytokines to kill the infected cells (4, 5).
What is upregulation receptors?
Upregulation: An increase in the number of receptors on the surface of target cells, making the cells more sensitive to a hormone or another agent. For example, there is an increase in uterine oxytocin receptors in the third trimester of pregnancy, promoting the contraction of the smooth muscle of the uterus.
What factors regulate expression of MHC II molecules?
The MHC class II enhanceosome is shown resulting from recruitment of different binding factors including regulatory factor X (RFX), cyclic AMP responsive element-binding protein (CREB) and nuclear transcription factor Y (NF-Y) to the S, X, X2 and Y box sequences located in the proximal promoter region.
What is the function of MHC class II?
Abstract. The main function of major histocompatibility complex (MHC) class II molecules is to present processed antigens, which are derived primarily from exogenous sources, to CD4(+) T-lymphocytes. MHC class II molecules thereby are critical for the initiation of the antigen-specific immune response.
Why is MHC-I expression important?
Clinical Importance of Loss of MHC I Expression In Cancers As discussed above, the loss of MHC I antigen presentation will make cancers less visible to the immune system and this is predicted to impair control of such tumors by CD8 T cells.
Where does MHC restriction occur?
The major histocompatability complex (MHC) codes for HLA antigens present on white cells and body tissues (Figure 2-5). It consists of several subloci, each of which has multiple alleles. Class I antigens occur at the A, B, and C subloci and are present on all nucleated body cells.
What is CTLs in immunology?
Cytotoxic T lymphocytes (CTLs) play a crucial role in the infections and the antitumor immunity. Induction and activation of antigen-specific CTLs is an important strategy in immunotherapy for various diseases, and several researchers have focused on the modulation of CTL induction and function.
How common is MHC-I downregulation in tumors?
Downregulation of MHC-I has been described in 40–90% of human tumors [9,12,13,14,15,16,17,18,19,20], often correlating with worse prognosis [18,21,22,23,24,25,26,27,28,29]. Both adult and pediatric tumors are able to reduce MHC-I surface display by the use of different regulatory mechanisms.
What are reversible MHC-I dysregulations?
Reversible MHC-I dysregulations are characterized by the coordinated (post-)transcriptional downregulation of the HLA class I heavy chain, components of the APM, or β2M and have been observed in several types of tumors, including HNSCC, bladder cancer, and neuroblastoma [18,19,20].
How is MHC-I antigen presentation regulated by multiple pathways?
Conclusions In conclusion, MHC-I antigen presentation is a complex process regulated by multiple pathways that can be pharmacologically targeted on multiple levels to increase pathway activation and trigger MHC-I expression in cancer.
What are the negative regulators of MHC-I in neuroblastoma?
The pediatric tumor neuroblastoma is well known for its low MHC-I expression. We have previously identified two major negative regulators of MHC-I via NFkB signaling in neuroblastoma: Nedd4 Binding Protein 1 (N4BP1) and TNFα-induced protein 3 interacting protein 1 (TNIP1) [54].